Bora Pharmaceuticals Co., Ltd. Announces Q1 2026 EPS of NT$0.21
NQ Score
0/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Bora Pharmaceuticals Co., Ltd. has released its financial results for the first quarter of 2026, reporting an earnings per share (EPS) of NT$0.21, operating revenue of NT$4.001 billion, and net profit after tax of NT$0.32 billion. These figures highlight the company's financial performance within the biotechnology and medical industry.